Rifamycin SV

Rifamycin SV is a lipid of Polyketides (PK) class. Rifamycin sv is associated with abnormalities such as Cholestasis, Infection, Dysentery, Soft Tissue Infections and Osteomyelitis. The involved functions are known as Uptake, Excretory function, Drug Kinetics, inhibitors and anaphylaxis. Rifamycin sv often locates in Hepatic, Blood, soluble, Entire gastrointestinal tract and Membrane. The associated genes with Rifamycin SV are SLCO1C1 gene, SLCO1B1 gene, ABCB11 gene and SLC10A1 gene.

Cross Reference

Introduction

To understand associated biological information of Rifamycin SV, we collected biological information of abnormalities, associated pathways, cellular/molecular locations, biological functions, related genes/proteins, lipids and common seen animal/experimental models with organized paragraphs from literatures.

What diseases are associated with Rifamycin SV?

Rifamycin SV is suspected in Tuberculosis, Cholestasis, Infection, Dysentery, Soft Tissue Infections, Osteomyelitis and other diseases in descending order of the highest number of associated sentences.

Related references are mostly published in these journals:

Disease Cross reference Weighted score Related literature
Loading... please refresh the page if content is not showing up.

Possible diseases from mapped MeSH terms on references

We collected disease MeSH terms mapped to the references associated with Rifamycin SV

MeSH term MeSH ID Detail
Plaque, Amyloid D058225 19 associated lipids
Arthralgia D018771 8 associated lipids
Tuberculosis, Pulmonary D014397 18 associated lipids
Synovitis D013585 15 associated lipids
Pain D010146 64 associated lipids
Osteomyelitis D010019 10 associated lipids
Intraoperative Complications D007431 5 associated lipids
Hyperbilirubinemia D006932 11 associated lipids
Hydrarthrosis D006833 1 associated lipids
Hemophilia A D006467 10 associated lipids
Per page 10 20 | Total 18

PubChem Associated disorders and diseases

What pathways are associated with Rifamycin SV

There are no associated biomedical information in the current reference collection.

PubChem Biomolecular Interactions and Pathways

Link to PubChem Biomolecular Interactions and Pathways

What cellular locations are associated with Rifamycin SV?

Related references are published most in these journals:

Location Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

What functions are associated with Rifamycin SV?


Related references are published most in these journals:

Function Cross reference Weighted score Related literatures

What lipids are associated with Rifamycin SV?

There are no associated biomedical information in the current reference collection.

What genes are associated with Rifamycin SV?

Related references are published most in these journals:


Gene Cross reference Weighted score Related literatures

What common seen animal models are associated with Rifamycin SV?

There are no associated biomedical information in the current reference collection.

NCBI Entrez Crosslinks

All references with Rifamycin SV

Download all related citations
Per page 10 20 50 100 | Total 175
Authors Title Published Journal PubMed Link
Sayyed K et al. Alteration of human hepatic drug transporter activity and expression by cigarette smoke condensate. 2016 Toxicology pmid:27450509
Furet Y et al. [Mixed hepatitis due to rifamycin SV. Apropos of a case]. 1986 Sep-Oct Therapie pmid:3810533
Freymuth F et al. [In vitro activity of rifamycin SV on herpes simplex and herpes varicella viruses]. 1983 May-Jun Therapie pmid:6310814
Zhao J et al. Preparation and application of rifamycin-capped (3-(2-O-β-cyclodextrin)-2-hydroxypropoxy)-propylsilyl-appended silica particles as chiral stationary phase for high-performance liquid chromatography. 2010 Talanta pmid:21035677
Marchesoni A et al. Rifamycin SV versus triamcinolone in local treatment of rheumatoid synovitis. 1993 Scand. J. Rheumatol. pmid:8356413
Spisani S et al. The effect of rifamycin SV on neutrophil functions in patients with rheumatoid arthritis. 1982 Scand. J. Rheumatol. pmid:7089503
Păunescu E et al. [Preliminary results of the use of a new derivative of rifamycin SV in the treatment of sarcoidosis]. 1982 Apr-Jun Rev Ig Bacteriol Virusol Parazitol Epidemiol Pneumoftiziol Pneumoftiziol pmid:6294806
Crance JM et al. Inhibition of sandfly fever Sicilian virus (Phlebovirus) replication in vitro by antiviral compounds. 1997 Sep-Oct Res. Virol. pmid:9403935
Velichka D et al. Experimental and clinical studies on Rifacinna--the new effective antituberculous drug (review). 2010 Recent Pat Antiinfect Drug Discov pmid:19929844
Evans SE et al. The ansamycin antibiotic, rifamycin SV, inhibits BCL6 transcriptional repression and forms a complex with the BCL6-BTB/POZ domain. 2014 PLoS ONE pmid:24595451